DEVELOPMENT OF SECONDARY ANAEMIA IN PATIENTS WITH DIFFERENTIATED THYROID CANCER TREATED WITH RADIOTHERAPY
Relevance. Thyroid cancer is one of the most prevalent endocrine cancers, which makes the study of issues related to its variants and complications arising during treatment relevant. Secondary anaemia may occur in patients with differentiated thyroid cancer treated with radiotherapy.
Aim of this study was to analyse the potential of using hypocalcaemia as a predictor of onset of secondary anaemia after radiotherapy in differentiated thyroid cancer patients.
Materials and methods. The study covered a cohort of 120 differentiated thyroid cancer patients treated using conventional methods (including surgery, radiotherapy and hormonotherapy). The occurrence and development of complications in the form of secondary anaemia were analysed.
Results. Blood calcium under 2.2 mmol/L in thyroid cancer patients prior to radiotherapy represents a risk factor for the occurrence of secondary anaemia. Calcium deficiency must be monitored and treated in order to avoid this complication.
Conclusions. Onset of secondary anaemia is correlated to hypocalcaemia in thyroid cancer patients with hypoparathyroidism. Blood calcium must be monitored prior to radiotherapy during treatment of thyroid cancer.
Yevheniia B. Radzishevska1,2, https://orcid.org/0000-0003-3437-3916
Yaroslava K. Radzishevska3, https://orcid.org/0000-0003-0770-3852
Maria Kuksin4, https://orcid.org/0000-0003-0770-3852
Antonina S. Savchenko1,5, https://orcid.org/0000-0002-7055-117X
Аleksej N. Boyko3, https://orcid.org/0000-0003-2865-2951
1 SE «Institute of Medical Radiology named after S.P. Grigoriev» of the National Academy of Medical Sciences of Ukraine, Kharkiv, Ukraine;
2 Kharkiv National Medical University, Kharkiv, Ukraine;
3City clinical hospital N°27, non-profit organisation of Kharkiv city council
The municipal enterprise «Kharkiv City Clinical Hospital №27», Kharkiv, Ukraine;
4 Ecole Normale Superieure, Lyon, France;
5 Kharkiv State University named after V.N.Karazin, Kharkiv, Ukraine
1. Радзішевська Є.Б., Васильєв Л.Я., Кулініч Г.В. Результати аналізу безпосередніх ускладнень протипухлинного лікування у хворих на рак щитоподібної залози // Украинский радиологический журнал. 2017; 25(4): 268 276.
2. Bove A., Di Renzo R.M., Palone G., D'Addetta V., Percario R., Panaccio P., Bongarzoni G. Early biomarkers of hypocalcemia following total thyroidectomy // International Journal of Surgery, 2014. 12. P 202 204. doi:10.1016/j.ijsu.2014.05.008.
3. Eismontas V., Slepavicius A., Janusonis V., Zeromskas P., Beisa V., Strupas K., Dambrauskas Z., Gulbinas A., Martinkenas A. Predictors of postoperative hypocalcemia occurring after a total thyroidectomy: results of prospective multicenter study // BMC Surgery. 2018 18:55. Doi: 10.1186/s12893-018-0387-2.
4. Gac P.E., Cabane P.T., Amart J.V., Huidobro F.G., Rossi R.F., Rodrigues F., Ferrada C.V., Cardemi F.R. Incidence of hypocalcaemia after total thyroidectomy // Rev Med Chile. 2007. 135. рр.26-30.
5. Gianoukakis A.G., Leigh M.J., Richards P., Christenson P.D., Hakimian A., Fu P., Niihara V., Smith T.J. Characterization of the anemia associated with Graves’ disease // Clin Endocrinol (Oxf). 2009 May; 70(5): 781–787. Doi: 10.1111/j.1365-2265.2008.03382.x.
6. Graff A.T., Miller F.R., Roehm C.E. et. Al. Predicting hypocalcemia after total thyroidectomy: parathyroid hormone level vs.serial calcium levels. Ear Nose Throat J. 2010. 89:462–465.
7. Grimm D. Current Knowledge in Thyroid Cancer—From Bench to Bedside // Int. J. Mol. Sci. 2017, 18, 1529. Doi: 10.3390/ijms18071529.
8. Kakava K., Tournis S., Papadakis G., Karelas I., Stampouloglou P., Kassi E., Triantafillopoulos I., Villiotou V., Karatzas T. Postsurgical Hypoparathyroidism: A Systematic Review. In vivo 30: 171-180 (2016). Doi: 2016;30:171-9.
9. Komarovskiy K., Raghavan S. Hypocalcemia following treatment with radioiodine in a child with graves’ disease // Thiroid; Vol.22, № 2, 2012, P. 218-222. Doi:10.1089/thy.2011.0094.
10. Merchavy S., Marom T., Forest V. I., Hier M., Mlynarek A., McHugh T., Payne R. Comparison of the Incidence ofPostoperative Hypocalcemia following Total Thyroidectomy vs Completion Thyroidectomy // Otolaryngology–Head and Neck Surgery. 2015, Vol. 152(1) 53–56. Doi: 10.1177/0194599814556250.
11. M'Rabet-Bensalah K., Aubert C.E., Coslovsky M., Collet T.H. Thyroid dysfunction and anaemia in a large population-based study // Clinical endocrinology. 2016 Apr Volume: 84 Issue: 4 Pages: 627-31. Doi: 10.1111/cen.12994.
12. Muller S., Senne M., Kirschniak A., BaresR., Falch C. Impact of surgical resection extension on outcome for primary well-differentiated thyroid cancer – a retrospective analysis // World J. of surgical oncology. 2017, 15:190. Doi:10.1186/s12957-017-1261-x
13. Noureldine S. I., Genther D. J., Lopez M., Agrawal N., Ralph P. Tufano. Early predictors of hypocalcemia after total thyroidectomy an analysis of 304 patients using a short-stay monitoring protocol // JAMA Otolaryngol Head Neck Surg. 2014; 140(11):1006-1013. doi: 10.1001/jamaoto.2014.2435.
14. Pellegriti G., Frasca F., Regalbuto C., Squatrito S., Vigneri R. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors // J Cancer Epidemiol. 2013; 2013 : 965212. Doi:10.1155/2013/965212.
15. Perris A.D., Whitfield J.F., Rixon R.H. Stimulation of mitosis in bone marrow and thymus of normal and irradiated rats by divalent cations and parathyroid extract // Radiation Res.,1967, 32(3): 550 563. Doi: 10.2307/3572266.
16. Perris A.D., Whitfield J.F. Calcium homeostasis and erytropoietic control in the rat. Canad // J. Physiol. Pharmacol., 1967, 49: 22 35. Doi: 10.1139/y71-004.
17. Puzziello A., Rosato L., Innaro N., et al. Hypocalcemia following thyroid surgery: incidence and risk factors. A longitudinal multicenter study comprising 2,631 patients // Endocrine 47, 537-542 (2014). Doi: 10.1007/s12020-014-0209-y.
18. Prinsen H.T., Klein Hesselink E.N., Brouwers A.H. et al. Bone Marrow Function After 131I Therapy in Patients With Differentiated Thyroid Carcinoma // J Clin Endocrinol Metab, October 2015, 100(10):3911–391. Doi: 10.1210/jc.2015-2124.
19. Rixon R.H. Mitotic activity in the bone marrow of rats and its relation to the level of plasma calcium // Curr. Mod. Biol. 1968, 2: 68 74. Doi: 10.1016/0303-2647(68)90010-5.
20. Rixon R.H., Whitfield J.F. Hypoplasia of the Bone Marrow in Rats following removal of the Parathyroid Glands // Cell. Physiol., 1971, 79: 343 352. Doi: 10.1002/jcp.1040790304.
21. Roh Jong-Lyel, Park Jae-Yong, Park Chan I.I. Prevention of postoperative hypocalcaemia with routine oral calcium and vitamin d supplements in patients with differentiated papillary thyroid carcinoma undergoing total thyroidectomy plus central neck dissection // Cancer 2009; 115 : 251-8. doi: 10.1002/cncr.24027.
22. Szczepanek-Parulska E., Hernik A., Ruchala M.. Anemia in thyroid diseases // Polish archives of internal medicine. 2017; 127 (5). doi:10.20452/pamw.3985.
23. Tianpeng Hu, Zhaowei Meng, Guizhi Zhang, Qiang Jia, Jian Tan, Wei Zheng, Renfei Wang, Xue Li, Na Liu, Pingping Zhou, Arun Upadhyaya. Influence of the first radioactive iodine ablation on peripheral complete blood count in patients with differentiated thyroid cancer // Medicine. 2016. 95 : 35 (e4451). Doi:10.1097/MD.0000000000004451.
24. Ullmann T.M., Gray K.D., Moore M.D., Zarnegar R., Fahey T.J. Current controversies and future directions in the diagnosis and management of differentiated thyroid cancers // Gland Surg 2018; 7(5) : 473-486. Doi:10.21037/gs.2017.09.08.
25. Van Belle. What is the value of hemoglobin as a prognostic and predictive factor in cancer // EJC. Supplements, Vol.2, №2 (2004), P. 11-19. doi: 10.1016/S1359-6349(03)00103-4.
26. Vrndic O.B., Djurdjevic P.M, Jovanovic D.D., Teodorovic L., Mijatovic C., Kostic I.R., Jeftic I.D., Zivancevic-Simonovi S.T. Blood cells in thyroid cancer patients: a possible influence of apoptosis // Open Med. 2016; 11:87-92. doi: 10.1515/med-2016-0017.
27. Wang Ying-hao, Bhandari Adheesh, Yang Fan, Zhang Wei, Xue Li-jun, Liu Hai-guang, Zhang Xiao-hua, Chen Cheng-ze. Risk factors for hypocalcaemia and hypoparathyroidism following thyroidectomy: a retrospective chinese population study // Cancer Management and Research 2017:9 627-635. doi: 10.2147/CMAR.S148090.
28. Wopereis D.M., Du Puy R.S., Heemst D., Walsh J.P., Bremner A., Bakker S.J., Bauer D.C., Cappola A.R., Ceresini G., Degryse J., et al. The Relation Between Thyroid Function and Anemia: A Pooled Analysis of Individual Participant Data // J Clin Endocrinol Metab. 2018 Oct; 103(10): 3658–366. Doi: 10.1210/jc.2018-00481.
29. Yu Shi-Tong, Ge Jun-Na, Luo Jing-Yi, Wei Zhi-Gang, Sun Bai-Hui, Lei Shang Tong. Treatment-related adverse effects with TKLs in patients with advanced or radioiodine refractory differentiated thyroid carcinoma: a systematic review and meta-analysis // Cancer Management and Research 2019:11 1525-1532. doi:10.2147/CMAR.S191499.
Количество просмотров: 491
Категория статей:
Оригинальные исследования
Библиографическая ссылка
Радзишевская Е.Б., Радзишевская Я.К., Куксин М., Савченко А.С., Бойко А.Н. Развитие вторичных анемий у больных дифференцированным раком щитовидной железы на фоне радиойодтерапии // Наука и Здравоохранение. 2020. 2(Т.22). С. 66-71. doi 10.34689/SH.2020.22.2.007Похожие публикации:
МЕХАНИКАЛЫҚ САРҒАЮ ОПЕРАЦИЯСЫ КЕЗІНДЕ КОАГУЛОПАТИЯЛЫҚ ҚАН КЕТУДІҢ АЛДЫН АЛУ ӘДІСІ
ОПТИМИЗАЦИЯ РЕЗУЛЬТАТОВ АУТОДЕРМОПЛАСТИКИ ПРИ ЛЕЧЕНИИ ГРАНУЛИРУЮЩИХ ГНОЙНЫХ РАН
BASICS OF REHABILITATION OF CHILDREN AFTER OPERATIONS ON THE COLON AND ANORECTAL AREA
HEALTH INDICATORS OF FIRST-YEAR-OF-LIFE CHILDREN IN THE REPUBLIC OF KAZAKHSTAN FOR 2013-2022
ОЦЕНКА УДОВЛЕТВОРЕННОСТИ ТРУДОВОЙ ДЕЯТЕЛЬНОСТЬЮ ВРАЧЕЙ АНЕСТЕЗИОЛОГОВ-РЕАНИМАТОЛОГОВ ГОРОДА АСТАНА